QSOX2 Upregulated in triple-negative breast cancer exacerbates patient prognosis by stabilizing integrin β1

QSOX2 Upregulated in triple-negative breast cancer exacerbates patient prognosis by stabilizing integrin β1

Breast cancer (BC) remains a significant global health threat, with triple-negative breast cancer (TNBC) standing out as a particularly aggressive subtype lacking targeted therapies. Addressing this gap, we propose Quiescin Q6 sulfhydryl oxidase 2 (QSOX2) as a potential therapeutic target, a disulfi...

Full description

Bibliographic Details
Main Authors: A-In Kim, Ji Hoon Oh, Je-Yoel Cho
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Heliyon
Subjects:
QSOX2
Triple negative breast cancer
Patient prognosis
Integrin β1
Protein stability
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024031797

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024031797

Similar Items